EVALUATION OF THE EFFICACY OF TEST FORMULATIONS IN MOUSE MODEL OF MPTP-INDUCED PARKINSON’S DISEASE
1.0 TEST SYSTEM DETAILS:
Species :Mus musculus(Mouse)
Strain : C57BL/6
Age : 6-8 weeks
Body Weight : 22- 25g
Sex : Male/ Female
No. of animals : 10 animals /Group
Total animals : 110
Study duration : 40 days
2.0 ALLOCATION OF GROUPS:
Groups |
Treatment |
Dose; ROA |
No. of Animals |
G1 |
Normal
Control |
0.5%
MC, p.o. |
10 |
G2 |
Disease
Control |
0.5%
MC, p.o. |
10 |
G3 |
Reference
Control – Selegiline |
3
mpk, p.o. |
10 |
G4 |
Test Formulation 1 |
X1
mpk; p.o. |
10 |
G5 |
Test Formulation 1 |
X2
mpk; p.o. |
10 |
G6 |
Test Formulation 1 |
X3
mpk; p.o. |
10 |
G7 |
Test Formulation 1 |
X4
mpk; p.o. |
10 |
G8 |
Test Formulation 2 |
Y1
mpk; p.o. |
10 |
G9 |
Test Formulation 2 |
Y2
mpk; p.o. |
10 |
G10 |
Test Formulation 2 |
Y3
mpk; p.o. |
10 |
G11 |
Test Formulation 2 |
Y4
mpk; p.o. |
10 |
No extra animals will be taken; X1, X2, X3, X4 and Y1, Y2, Y3, Y4 are defined as the incremental doses of the Test formulations. MC-Methyl Cellulose; ROA-route of administration; mpk-mg/kg, p.o.-per os
3.0 METHOD:
· Animals will be
procured, randomized based on body weight and allocated into 11 different
groups consisting of 10 animals each.
·
Animals of Group G1
will serve as Normal control and will receive 0.5% MC, p.o.
·
Animals of Group G2
will serve as disease control group will receive 0.5% MC, p.o.
·
Animals of Group G3
will serve as reference control and treated with 3 mg/kg selegiline
p.o.
·
Animals of Group G4 to
G11 will be treated with test compounds at respective dose levels.
·
Basal neurobehavioral readings
will be assessed, prior to MPTP injection for all groups.
· Three days before MPTP treatment, mice will be given the drug treatment orally.
Drug treatment will be continued for a total of 18 days.
· To construct the model, mice will be injected with MPTP (dissolved in
0.9% saline, 30mg/kg, intraperitoneally) for 5 consecutive days, while the normal
control group will be given an equal volume of normal saline, intraperitoneally.
·
Two days after the last MPTP injection, behavioural assessments will be performed
using the open field test, pole test and rotarod test.
Collection and Measurement
of Specimens:
· On Day 19, blood will be collected from the retro-orbital sinus and subsequently the animals will be euthanized with an overdose of thiopentone followed by collection of brain for histopathological, biochemical and molecular evaluation.
4.0 END POINT
PARAMETER(S):
·
Clinical observation
·
Body weight
·
Open field test
·
Rotarod test
· Pole test
· Narrow beam Test
·
Histopathology and immunohistochemistry of the brain
· High-performance liquid chromatography (HPLC) for the estimation of
neurotransmitters in the brain
·
Western blot analysis of the brain
·
Measurement of Cytokines in the brain
· qPCR in the brain
5.0 REFERENCES:
1. Zhang, Qiu-shuang, et al. "Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease." Acta Pharmacologica Sinica 38.10 (2017): 1317-1328.
2.
Lee, Eunju, et al. "MPTP-driven NLRP3
inflammasome activation in microglia plays a central role in dopaminergic
neurodegeneration." Cell Death & Differentiation 26.2
(2019): 213-228.
END OF THE DOCUMENT
You may like to read these links:
1. List of All SOPs and Documents for the Microbiology Laboratory
2. List of All SOPs and Documents for In-vitro Laboratory
3. List of All SOPs and Documents for the In-vivo Laboratory.
4. List of All SOPs and Documents for Clinical Research
5. List of Instruments and Equipment Used In Laboratory Animal Facility
6. Animal Facility Design - Small Laboratory Animals (Rat, Mice, Rabbit, Guinea Pig)
7. List of Chemicals Needed for In-vivo Laboratory
8. List of Physiological Data for Small Laboratory Animals
9. List of All SOPs and Documents for the Animal House Facility
10. List of Instrument for Pharmacology Laboratory for College
11. List of In-vivo Laboratory (Animal Facility) Vendors
12. List of Histopathology Laboratory Instruments
0 comments:
Post a Comment